Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci

Carcinogenesis

Volumn 37, Issue 1, 2016, Pages 96-105

  Kachuri, Linda ^a,b   Amos, Christopher I ^c   McKay, James D ^d   Johansson, Mattias ^d   Vineis, Paolo ^e,f   Bueno de Mesquita, H Bas ^f,g,h,i   Boutron Ruault, Marie Christine ^j,k,l   Johansson, Mikael ^m   Quirós, J Ramón ⁿ   Sieri, Sabina ^o   Travis, Ruth C ^p   Weiderpass, Elisabete ^q,r,s,t   Le Marchand, Loic ^u   Henderson, Brian E ^u   Wilkens, Lynne ^u   Goodman, Gary E ^v   Chen, Chu ^v   Doherty, Jennifer A ^c   Christiani, David C ^w,x   Wei, Yongyue ^w   Su, Li ^w   Tworoger, Shelley ^w,y   Zhang, Xuehong ^y   Kraft, Peter ^w   Zaridze, David ^z   Field, John K ^aa   Marcus, Michael W ^aa   Davies, Michael P A ^aa   Hyde, Russell ^aa   Caporaso, Neil E ^ab   Landi, Maria Teresa ^ab   Severi, Gianluca ^{e,j,k,l,ac,ad}   Giles, Graham G ^ac,ad,ae   Liu, Geoffrey ^b,af   McLaughlin, John R ^a,ag   Li, Yafang ^c   Xiao, Xiangjun ^c   Fehringer, Gord ^a   Zong, Xuchen ^a   Denroche, Robert E ^ah   Zuzarte, Philip C ^ah   McPherson, John D ^ah   Brennan, Paul ^d   Hung, Rayjean J ^a,b   more..

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e Human Genetics Foundation   (Italy)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ UNIVERSITY OF MALAYA   (Malaysia)

^j INSERM   (France)

^k UNIVERSITÉ PARIS SACLAY   (France)

^l INSTITUT GUSTAVE ROUSSY   (France)

^m UMEÅ UNIVERSITY   (Sweden)

ⁿ PUBLIC HEALTH DIRECTORATE   (Spain)

^o NATIONAL CANCER INSTITUTE   (Italy)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q UNIVERSITY OF TROMSØ   (Norway)

^r CANCER REGISTRY OF NORWAY   (Norway)

^s KAROLINSKA INSTITUTE   (Sweden)

^t FOLKHÄLSAN RESEARCH CENTER   (Finland)

^u UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^v Fred Hutchinson Cancer Research Center   (United States)

^w HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^x MASSACHUSETTS GENERAL HOSPITAL   (United States)

^y BRIGHAM AND WOMEN S HOSPITAL   (United States)

^z N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^aa UNIVERSITY OF LIVERPOOL   (United Kingdom)

^ab NATIONAL CANCER INSTITUTE   (United States)

^ac CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ad UNIVERSITY OF MELBOURNE   (Australia)

^ae MONASH UNIVERSITY   (Australia)

^af PRINCESS MARGARET HOSPITAL   (Canada)

^ag PUBLIC HEALTH ONTARIO   (Canada)

^ah ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHROMOSOME 5P; CHROMOSOME 5P15.33; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL LUNG CARCINOMA; TELOMERE HOMEOSTASIS; CHROMOSOMAL MAPPING; CHROMOSOME 5; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; LUNG TUMOR; MIDDLE AGED; PROCEDURES;

CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 84954348464     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv165     Document Type: Article

References (48)

1. Jemal, A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
2. Brennan, P. et al. (2011) Genetics of lung-cancer susceptibility. Lancet Oncol., 12, 399-408.
3. McKay, J.D., et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat. Genet., 40, 1404-1406.
4. Wang, Y. et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet., 40, 1407-1409.
5. Rafnar, T., et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet., 41, 221-7.
6. Landi, M.T., et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet., 85, 679-91.
7. Hsiung, C.A. et al. (2010) The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet., 6.
8. Lan, Q. et al. (2012) Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat. Genet., 44, 1330-1335.
9. Shiraishi, K. et al. (2012) A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat. Genet., 44, 900-903.
10. Walsh, K.M. et al. (2013) Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol. Biomarkers Prev., 22, 251-260.
11. Newbold, R.F. (2002) The significance of telomerase activation and cellular immortalization in human cancer. Mutagenesis, 17, 539-550.
12. Bodnar, A.G. et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349-352.
13. Yamamoto, K. et al. (2001) A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem. Biophys. Res. Commun., 280, 1148-1154.
14. James, M.A. et al. (2014) CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis. Cancer Res., 74, 1116-1127.
15. Toh, C.K. et al. (2006) Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J. Clin. Oncol., 24, 2245-2251.
16. Sun, S. et al. (2007) Lung cancer in never smokers-a different disease. Nat. Rev. Cancer, 7, 778-790.
17. Timofeeva, M.N. et al. (2012) Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum. Mol. Genet., 21, 4980-95.
18. Truong, T. et al. (2010) Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J. Natl. Cancer Inst., 102, 959-971.
19. Wang, Z., et al. (2014) Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum. Mol. Genet, 23, 6616-6633.
20. Kote-Jarai, Z., et al. (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat. Genet., 43, 785-91.
21. Petersen, G.M. et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet., 42, 224-228.
22. Kinnersley, B., et al. (2012) The TERT variant rs2736100 is associated with colorectal cancer risk. Br. J. Cancer, 107, 1001-1008.
23. Walsh, K.M., et al. (2014) Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat. Genet., 46, 731-5.
24. Savage, S.A. et al. (2005) Genetic variation, nucleotide diversity, and linkage disequilibrium in seven telomere stability genes suggest that these genes may be under constraint. Hum. Mutat., 26, 343-350.
25. Wang, Y., et al. (2015) Deciphering associations for lung cancer risk through imputation and analysis of 12 316 cases and 16 831 controls. Eur. J. Hum. Genet, 23, 1723-1728.
26. Pande, M. et al. (2011) Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis, 32, 1493-1499.
27. Pritchard, J.K. et al. (2000) Inference of population structure using multilocus genotype data. Genetics, 155, 945-959.
28. Zuzarte, P.C. et al. (2014) A two-dimensional pooling strategy for rare variant detection on next-generation sequencing platforms. PLoS One, 9, e93455.
29. Brenner, D.R. et al. (2010) Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors. BMC Cancer, 10, 285.
30. Affymetrix Inc. (2014) Axiom Genotyping Solution Data Analysis Guide: P/N 702961 Rev. 2.
31. Cawthon, R.M. (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res., 30, e47.
32. Sanchez-Espiridion, B. et al. (2014) Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians. Cancer Res., 74, 2476-2486.
33. Lee, S., et al. (2012) Optimal unified approach for rare-variant association testing with application to small-sample case-control wholeexome sequencing studies. Am. J. Hum. Genet., 91, 224-237.
34. Gao, X. et al. (2008) A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet. Epidemiol., 32, 361-369.
35. Purcell, S. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
36. Mägi, R. et al. (2010) GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics, 11, 288.
37. Pruim, R.J. et al. (2010) LocusZoom: regional visualization of genomewide association scan results. Bioinformatics, 26, 2336-2337.
38. Ehrlenbach, S. et al. (2009) Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay. Int. J. Epidemiol., 38, 1725-1734.
39. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
40. Adzhubei, I. et al. (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet., Chapter 7, Unit7.20.
41. Lantuejoul, S. et al. (2004) Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br. J. Cancer, 90, 1222-1229.
42. Lantuéjoul, S. et al. (2007) Telomerase expression in lung preneoplasia and neoplasia. Int. J. Cancer, 120, 1835-1841.
43. Blekhman, R. et al. (2008) Natural selection on genes that underlie human disease susceptibility. Curr. Biol., 18, 883-889.
44. Corona, E. et al. (2010) Extreme evolutionary disparities seen in positive selection across seven complex diseases. PLoS One, 5, e12236.
45. Brennan, P. et al. (2007) Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Hum. Mol. Genet., 16, 1794-1801.
46. Chen, X. et al. (2006) Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells. Proc. Natl. Acad. Sci. USA, 103, 11724-11729.
47. Mansilla, F. et al. (2009) Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J. Mol. Med. (Berl), 87, 85-97.
48. Zhou, X. et al. (2012) The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer. Exp. Mol. Pathol., 92, 105-110.